...
机译:多中心流式细胞术中急性髓细胞白血病最小残留疾病评估的预后价值
Hematology BiologyUniversity HospitalBordeaux France;
Hematology BiologyUniversity HospitalSaint Etienne France;
Hematology BiologyUniversity HospitalBordeaux France;
Hematology BiologyInstitut Paoli CalmettesMarseilles France;
Hematology BiologyH?pital Saint LouisParis France;
Hematology BiologyUniversity HospitalLille France;
Hematology BiologyUniversity HospitalLimoges France;
Hematology BiologyUniversity HospitalAngers France;
Hematology BiologyUniversity HospitalLimoges France;
Hematology BiologyUniversity HospitalDijon France;
Hematology BiologyUniversity HospitalCreteil France;
Hematology BiologyUniversity HospitalLille France;
Hematology BiologyUniversity HospitalDijon France;
Hematology BiologyUniversity HospitalSaint Etienne France;
Hematology BiologyUniversity HospitalCreteil France;
Hematology BiologyUniversity HospitalLille France;
Hematology DepartmentH?pital Robert DebréParis France;
Hematology DepartmentH?pital Saint LouisParis France;
Hematology DepartmentUniversity HospitalAngers France;
Hematology BiologyUniversity HospitalNantes France;
AML; Boolean gates; flow cytometry; MRD; survival;
机译:多中心流式细胞术中急性髓细胞白血病最小残留疾病评估的预后价值
机译:流式细胞术在急性淋巴细胞白血病中最小残留病评估的方法论方面:法国多中心研究
机译:流式细胞术和分子评估相结合提高了急性髓样白血病的移植前最小残留病的预后价值
机译:用单束声镊鉴别急性淋巴细胞白血病的最小残留病
机译:高灵敏度流式细胞术检测和监测多发性骨髓瘤可测量的残留疾病
机译:流式细胞术和WT1评估相结合提高了急性髓样白血病的移植前最小残留病的预后价值
机译:流式细胞术和IG / TCR定量PCR在急性淋巴细胞白血病中最小的残留疾病定量:代表FRALLE,EORTC和GRAALL的法国多中心前瞻性研究